Recce Pharmaceuticals Ltd
F:R9Q
Recce Pharmaceuticals Ltd
F:R9Q
Price:
0.324
EUR
14.08%
Market Closed
Market Cap:
€71.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Recce Pharmaceuticals Ltd
F:R9Q
|
AU |
|
Innovatec SpA
F:5JT
|
IT |
|
N
|
New World Resources Ltd
OTC:NWCBF
|
AU |
|
S
|
Suzuki Motor Corp
SWB:SUK
|
JP |
|
D
|
Doxa AB
XBER:1DO
|
SE |
|
Ai-Media Technologies Ltd
ASX:AIM
|
AU |
|
Ameren Corp
NYSE:AEE
|
US |
|
C
|
Cushman & Wakefield PLC
F:2IY
|
UK |
|
G
|
Givaudan SA
DUS:GIN
|
CH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is R9Q's stock price target?
Not Available
R9Q does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Recce Pharmaceuticals Ltd?
Projected CAGR
18%
18%
The compound annual growth rate for Revenue over the next 3 years is 18%.
